MLN0128 in Recurrent/Metastatic Merkel Cell Carcinoma

计划入组 9 人 · 首次发布于 2015 年 8 月 4 日

Cabozantinib in Recurrent/Metastatic Merkel Cell Carcinoma

计划入组 8 人 · 首次发布于 2014 年 1 月 15 日

Study of the Drug Ipilimumab for Metastatic Merkel Cell Carcinoma

首次发布于 2013 年 8 月 1 日

Avelumab(Bavencio)

NANT Merkel Cell Carcinoma Vaccine

renal cell carcinoma program

Peter Merkel

Germany

Gamida Cell

Israel

GAMIDA CELL INC.

United States

FDA Approves Bavencio: Merck KGaA and Pfizer's Breakthrough Immunotherapy for Rare Skin Cancer

Phio Pharmaceuticals Reports Promising Phase 1b Results for PH-762 in Cutaneous Squamous Cell Carcinoma

Verrica to Present VP-315 Immune Activation Data from Phase 2 Basal Cell Carcinoma Trial at SITC 2025